Nous avons ddj3 ddmontr~ sur des art&es canines ~picardiques de diff~rents calibres, que l'isoflurane, comme l'addnosine est un dilatateur prOf~rentiel des petites artbres coronaires, alors que lhalothane, comme la nitroglycOrine, est un dilatateur des grosses artbres. L~tude prdsente vise h comparer les effets directs du sdvoflurane avec ceux de l'isoflurane et de lhalothane. Chez le chien, on isole et sectionne en anneaux de grosses artbres coronaires d'un diambtre externe de 2,5 ~ 3,2 mm et des petites artbres coronaires distales de 0,6 3 0,9 ram. Elles sort pr~a-lablement contractOes avec du KCl (20 raM) et leurs propri~tds relaxantes en presence d'anesthOsiques sort compar~es ~ la r~ponse maximale provoqu~e par la papav&ine. I1 n'y a pas de difference entre le s~voflurane, l'halothane et l'isoflurane (MAC 1-3 humain); ils provoquent tous une relaxation art&ielle qui d~pend de la dose. L'effet relaxant du sdvoflurane est identique que ce soit sur les grosses ou les petites artbres. Cependant, la relaxation des grosses artbres en r~ponse 3 lhalothane (1,5-2,3%) est plus importante que celle des petites artbres (P < 0,01) et la r~ponse des petites art~res h l'isoflurane (3,5%) est plus marquee que celle des grosses artbres (P <
voflurane in dogs and rats, respectively. This discrepancy may, in part, be due to differences in experimental conditions, since in vivo findings are inevitably affected by changes in systemic haemodynamics, myocardial metabolism or contractility, the effects of other anaesthetics administered concurrently and the level of PaCO2. The last will be altered by depression of respiration or artificial ventilation. Therefore, in vitro study was undertaken to clarify the direct effect of sevoflurane on coronary arteries.
Furthermore, it is known that a preferential dilator of large epicardial arteries or resistance vessels may induce quite different changes in myocardial oxygenation in patients with coronary artery disease. Dilatation of epicardial vessels may relieve coronary spasm and increase collateral flow to the ischaemic area, whereas dilatation of the resistance vessels may induce coronary steal and worsen myocardial ischaemia. 8 Numerous studies have indicated that isoflurane is a preferential dilator of small vessels in the coronary circulation and may induce coronary steal. [9] [10] [11] [12] [13] The aim of the present study was to evaluate the direct effect of sevoflurane on coronary arteries of different sizes in vitro. The effects of isoflurane and halothane were included in order to evaluate the potential of sevoflurane to induce coronary steal in comparison with other anaesthetics.
Methods
The protocol was approved by the Kyoto University Animal Use Committee. Ten male mongrel dogs weighing 8-15 kg were anaesthetized with ketamine, 20 mg" kg -1 /v, and then killed by bleeding from the common carotid arteries. The heart was removed rapidly and the left anterior descending and circumflex branches of the left coronary artery were isolated. The proximal portions of these branches with outer diameters (o.d.) of 2.5-3.2 mm and distal portions of 0.6-0.9 mm o.d. were used for the study. Although helical strips of these arteries had been prepared previously,12 in the present study, the coronary arteries were cut into rings 3.5-4.5 mm long in order to obtain a larger number of preparations with similar o.d. from a single animal for comparison of the effects of three anaesthetics. The arterial rings were fLxed between hooks in a 10-ml organ bath containing Krebs' bicarbonate solution which was aerated with a mixture of 5% CO 2 and 95% 02 and maintained at 36.5-37.5~ The composition of Krebs' bicarbonate solution was (in mM) was NaC1, 118.2: KCI, 4.6: NaHCO3, 24.8: CaCI2, 2.5: MgSO4, 1.2: KH2PO4, 1.2: dextrose, 10, and the pH was 7.35-7.45 when aerated with the gas mixture. Isometric contractions and relaxations were displayed on an oscillograph (Ni]aondenki-Sanei Co., Tokyo, Japan). Resting tension was adjusted so that maximal contraction After contraction with 20 mM KC1 had been stabilized the rings were exposed to anaesthetic at 1-3 MAC (human MAC 15-17) for longer than ten minutes until the tension had been stabilized again. One anaesthetic was administered to each ring, and the order of application of each concentration was randomized. Vascular rings in which stabilization could not be achieved were excluded from the study.
The MAC values differ among species 18 because of differences in the sensitivity of the central nervous system to the anaesthetic or with distribution among organs. There is no reason to suppose that the sensitivity of vascular smooth muscle to the anaesthetic is altered by the difference in MAC among species. Therefore, in the present and previous 12 in vitro studies, we compared the effects of anaesthetics on canine arteries at equivalent human MAC values. 18 Sevoflurane, halothane and isoflurane were introduced in the gas mixture through agent-specific vaporizers (PPVz, Penlon, England for sevoflurane, Fluotec 3, Ohmeda, England for halothane and Fortec, Ohmeda for isoflurane). The concentration in the resulting gas mixture was monitored and adjusted using an Atom 303 anaesthetic agent monitor (Atom, Tokyo, Japan). The actual concentrations of these anaesthetics in the bathing solution were determined by gas chromatography (Hewlett Packard 589OA Gas Chromatography, Avondale, PV). The concentration of anaesthetics solved in the bathing solution was stabilized within ten minutes; they were 7.38 + 0.63 mM (n = 6), 1.01 _ 0.16 mM (n = 3) and 0.72 + 0.12 mM (n = 3) for 3.4% sevoflurane, 1.5% halothane and 2.3% isoflurane, respectively. At the end of each experiment, papaverine (10 4 M) was added to the bathing solution, and the changes in tension induced by each concentration of anaesthetic were expressed as percentages relative to the maximal relaxation induced by papaverine. Values are expressed as means +__ SEM. The responses of large versus small arteries were compared by Student's t test for unpaired data. Other data were analyzed by analysis of variance and the SNK test. Differences of P < 0.05 were considered significant. Drugs used were sevoflurane (Maruishi Pharmaceutical Co., Osaka, Japan), halothane (Takeda Pharmaceutical Co., Osaka), isoflurane (Dainabot, Osaka) and papaverine hydrochloride (Dai-nippon Pharmaceutical Co., Osaka).
Results
Sevoflurane (1.7-5.1%), halothane (0.8-2.3%) and isoflurane (1.2-3.5%) induced dose-dependent relaxations of arteries of both sizes (Figures 1-3) . Relaxation induced by halothane at 1.5-2.3% was greater in large arteries than in small ones, and relaxation induced by 3.5% isoflurane was greater in small arteries than in larger ones (Figure 2 ). In contrast, the magnitude of relaxation induced by sevoflurane (1.7-5.1%) was not different between small and larger arteries (Figure 3) .
When the effects of the three anaesthetics at equivalent human MAC were compared, the relaxant potencies on large arteries were ranked in the order halothane = sevoflurane > isoflurane at 2 MAC, and halothane > sevofhirane > isoflurane at 3 MAC. The relaxant potencies on small arteries were isoflurane > sevoflurane >> halothane at 2 and 3 MAC.
Discussion
Although epicardial arteries, even those of small diameter, differ from resistance vessels in terms of structure and function, in vitro small epicardial arteries often show reactivity to vasoactive agents similar to that of resistance vessels in vivo. 19,20 Miwa and Toda 2~ compared the susceptibility of isolated dog epicardial arteries of different sizes to the relaxant effect of adenosine, a well-known preferential dilator of resistance vessels in vivo. zl They showed that the rank order of relaxation induced by adenosine was distal artery (o.d. less than 0.3 ram) > medium artery (o.d. 0.5-0.8 ram) > proximal artery (o.d. greater than 1.5 ram). Similarly, in our previous study , 12 we showed that isolated epicardial arteries of o.d. less than 0.9 mm were more susceptible to the effect of adenosine, and less susceptible to nitroglycerin, than proximal, larger epicardial arteries, suggesting that the reactivity of the small epicardial arteries (o.d. _< 0.9 mm) used in our previous and present studies is similar to that of resistance vessels.
The present findings on the effects of halothane and .isoflurane on vascular rings of dog epicardial arteries were similar to our previous findings on helical strips of such arteries; 12 halothane was a preferential dilator of large epicardial arteries and isoflurane was a preferential dilator of small ones. These results suggest that isoflurane, like adenosine, is a dilator of resistance vessels. Recently, Conzen et al. 13 provided further evidence for this hypothesis by demonstrating with epiillumination and fluorescence microscopy that isoflurane at a clinically relevant concentration (1.5 ___ 0.14%) dilated epicardial arteries with an initial o.d. of 20-120 ~m in situ.
In contrast to isoflurane, the direct effect of sevoflurane on isolated coronary artery has not been reported. Thus, this is the first in vivo study which demonstrated that sevoflurane dilates KCl-contracted coronary arteries dosedependently. Moreover, it demonstrated that the magnitudes of relaxation induced by sevoflurane do not differ between large and small epicardial arteries. This indicates that sevoflurane, unlike isoflurane, is not a preferential dilator of small coronary arteries, and suggests that the dilator effect of sevoflurane on resistance vessels of the coronary circulation is less than that of isoflurane. This is consistent with previous in vitro fmdings in that sevoflurane-induced decrease in coronary vascular resistance was less prominent than that induced by isoflurane. 3.4 Similar fmdings were reported using the isolated rat heart by Larach and Schuler. 6 Drug-induced dilatation of resistance vessels increases blood flow to healthy regions of myocardium, although blood flow to ischaemic areas, in which resistance vessels are already maximally dilated, cannot be increased further. Thus, preferential dilators of resistance vessels such as dipyridamole can cause coronary steal and may worsen coronary ischaemia in patients who have collateraldependent ischaemic regions, S Therefore, the present fmdings suggest that the ability of sevoflurane to induce coronary steal is, even if it exists, less than that of isoflurane. The in vivo finding of Monohar and Parks ! and Cork et al. 7 that the subendocardial/subepicardial perfusion ratio was not altered by sevoflurane, whilst isoflurane has been reported to decrease this ratio, 7,11 also supports this hypothesis.
Dilatation of large coronary arteries, in contrast to that of resistance vessels, would be beneficial to patients with angina who have spasm of the large epicardial arteries or organic coronary artery stenosis with the ischaemic area perfused through collateral flow. The present study revealed that halothane over 0.8% (1 MAC) and sevoflurane over 3.4% (2 MAC) are dilators of large coronary arteries. However, the magnitudes of relaxation induced by anaesthetics up to the highest concentration tested were much smaller than those induced by vasodilators such as nitroglycerin. Therefore, based on the present in vitro findings, it seems unlikely that these anaesthetics exert any important beneficial effect on myocardial oxygenation in patients with coronary artery disease.
The present study examined the effect of anaesthetics on KCl-contracted arteries alone and did not examine the effect on arteries contracted with vasoactive agonists. We have recently demonstrated in human platelets that halothane specifically inhibits binding of thromboxane A 2 analogue to its binding site. 22 Therefore, one may suppose that the potential of anaesthetics, particularly halothane, to ameliorate coronary spasm may be greater than their potential to dilate KCl-contracted artery, if formarion of thromboxane A2 was involved in the aetiology of vasospasm. Further study is required to test this hypothesis.
In conclusion, the dilator effect of sevoflurane does not show preference for large or small epicardial arteries in an in vitro model. Thus, we speculate that sevoflurane is less likely to induce coronary steal than isoflurane in patients with coronary artery disease.
